A group of about 450 doctors as members who, for the past 8 years, through their clinical research, have been developing fundamentally new solutions to illnesses.
Message from the Chairman
As we enter the third millenium, our society is increasingly confronted with novel scientific challenges. A key goal is to improve the prevention and management of cancer, which is the second leading cause of mortality in France.
Because cancer is a major unresolved public health problem, we are all affected by the response that attending physicians can contribute.
Perceiving that progress in therapeutic advances was too slow and fragmented, in 1997 we created Gercor, to offer other options to cancer patients.
In an effort to ensure that all patients have access to our treatments, we have created a network that presently includes about 450 attending physicians in France and in several other countries worldwide, with an independent and dynamic structure as its core, which is well-suited for fulfilling our objectives.
Finally, we have developed this website to assist physicians in their practice and to provide a valuable source of information for patients and their families.
SOME KEY FIGURES SINCE 1997
About 450 investigators
More than 250 private or public centers in Europe
More than 14 partnerships in the pharmaceuticals industry
13 permanent employees, 5 of whom are clinical research officers